NVM Private Equity has invested £1.5 million of growth capital into Newcastle based hiPSC company Newcells Biotech alongside existing investors Northstar Ventures, who have provided a further £500k bringing the total round to £2 million.

Founded in 2015 and headquartered at the world-renowned International Centre for Life in Newcastle (an incubator space for young and established biotechnology companies) Newcells is a successful, early-stage, life-sciences spinout from Newcastle University, which is leading the way in the development of Human Induced Pluripotent Stem Cells (hiPSCs) for efficacy and toxicity testing in the drug development sector.